TMDA | Tanzania Medicines & Medical Devices Authority Home

First slide [1024x605]

Draft regulations of the Tanzania Medicines and Medical Devices (Good Storage and Distribution Practices) Regulations, 2021 for comments by stakeholders.

First slide [1024x605]

The Ministerial Advisory Board (MAB) in one of their ordinary meeting to discuss various regulatory issues. The meeting was held on 10th December, 2020 at TMDA offices in Dar es Salaam.

First slide [1024x605]

The Ministerial Advisory Board (MAB) in one of their ordinary meeting to discuss various regulatory issues. The meeting was held on 10th December, 2020 at TMDA offices in Dar es Salaam.

First slide [1024x605]

TMDA participated in 5th Tanzanian Industrial Products Exhibitions which took place from 3rd December, 2020 to 9th December, 2020 at Mwl J. K Nyerere Trade Fair Ground, Kilwa Road, Dar es Salaam.

First slide [1024x605]

TMDA Director General Mr. Adam Fimbo (seated centre) together with Director of Busines Support, Mr. Chrispin Severe and Dr. Diana Mwiru from University of Dar es Salaam Business School in a group photo with data enumerators during the special training on how to conduct a Service Delivery Survey to TMDA's clients. The SDS kick off meeting was held in Dar es Salaam on 8th December, 2020.

First slide [1024x605]

Chief Medical Officer, Dr. Abel Makubi, officiate the kickoff meeting for the ASCEND Project which aimed at moving Tanzania’s Clinical Research Ethics and Medicines Regulatory capacity to the next level by fostering medicine quality, safety and GCP on clinical trials. The meeting was held on 26th November 2020 in Dar salaam. Other institutions that will collaborate to implement the ASCEND project which take 30 months includes NIMR, KCRI, MUHAS, ZFDA, ZAHRI and St. Andrew’s University of UK.

First slide [1024x605]

Chief Medical Officer, Dr. Abel Makubi, officiate the kickoff meeting for the ASCEND Project which aimed at moving Tanzania’s Clinical Research Ethics and Medicines Regulatory capacity to the next level by fostering medicine quality, safety and GCP on clinical trials. The meeting was held on 26th November 2020 in Dar salaam. Other institutions that will collaborate to implement the ASCEND project which take 30 months includes NIMR, KCRI, MUHAS, ZFDA, ZAHRI and St. Andrew’s University of UK.

First slide [1024x605]

Drug Inspector, Dr. Daniel Fussy receiving a certificate from TMDA Director General (center), Mr. Adam Mitangu Fimbo during a closing ceremony of the training on Medicines Evaluation and Registration which was held from 16th – 20th November, 2020 at SoP-MUHAS

First slide [1024x605]

TMDA Acting Manager, Medicines Registration, Mr. Felchism Apolnary presenting a topic on medicines evaluation during the training conducted by the Regional Centre of Regulatory Excellence (RCORE) in Medicines Evaluation and Registration that was held from 16th – 20th November, 2020 at MUHAS in DSM

First slide [1024x605]

Tanga Regional Commissioner, Hon. Martine Shigela presenting his speech to officiate the training of the Medicines Inspectors from Tanga region. The training was held from 09th to 13th November, 2020.

First slide [1024x605]

Tanga Regional Commissioner, Hon. Martine Shigela in a group photo with TMDA officials immediately after gracing the training for Medicines Inspectors from Tanga region. The training was held from 09th to 13th November, 2020 in Tanga city.

First slide [1024x605]

TMDA Eastern Zone Manager, Mr. Adonis Bitegeko, presenting a topic on code of ethics to inspectors during the training conducted by TMDA to Medicines Inspectors from Tanga region that was held from 09th to 13th November, 2020.

First slide [1024x605]

First slide [1024x605]

First slide [1024x605]

A group photo of participants in the training on Active Toxicity Monitoring of Adverse Drug Reactions associated with the use of Dolutegravir (DTG), a recently introduced Anti-Retroviral Therapy (ART) for People Living with HIV/AIDS. The training which was held from 28th-29th September, 2020 took place at TMDA Conference Hall comprises representatives of healthcare providers from 21 Care and Treatment Centres (CTC) from 8 regions of Tanzania.

First slide [1024x605]

Acting Director of Medicines and Medical Devices, Mr. Akida Khea, officiating the training on Active Toxicity Monitoring of Adverse Drug Reaction associated with use of Dolutegravir (DTG), a recently introduced Anti-Retroviral Therapy (ART) for People Living with HIV/AIDS.The training which is held from 28th-29th September, 2020 took place at TMDA Conference Hall comprises representatives of healthcare providers from 21 Care and Treatment Centres (CTC) in Tanzania.

First slide [1024x605]

TMDA Drug Inspector, Boniphace Likati contributing a point in an ordinary meeting that was held between Acting Director General, Mr. Adam Fimbo and Eastern Zone staff to discuss various regulatory issues. The meeting was held on 25th September, 2020 at Eastern Zone Offices based in Dar es Salaam.

First slide [1024x605]

Director General for TMDA, Mr. Adam Fimbo in an ordinary meeting with Eastern Zone staff to discuss various regulatory issues. The meeting was held on 25th September, 2020 at Eastern Zone Offices based in Dar es Salaam.

First slide [1024x605]

Permanent Secretary ( Health) Prof. Mabula Mchembe has launched new inspectors identity cards (IDs) which will be used by all inspectors of medicines, medical devices and diagnostics while performing regulatory activities. The newly introduced IDs are expected to mitigate the challenges of rogue inspectors. The event which took place at TMDA Lake Zone Offices based in Mwanza was held on 16th September, 2020 and attended by Members of Ministerial Advisory Board to TMDA, Manegement and drugs inspectors from both TMDA and LGAs. The TMDA lake Zone Office serving six regions comprised of Mwanza, Mara, Simiyu, Kagera, Geita and Shinyanga.

First slide [1024x605]

Permanent Secretary ( Health) Prof. Mabula Mchembe has launched new inspectors identity cards (IDs) which will be used by all inspectors of medicines, medical devices and diagnostics while performing regulatory activities. The newly introduced IDs are expected to mitigate the challenges of rogue inspectors. The event which took place at TMDA Lake Zone Offices based in Mwanza was held on 16th September, 2020 and attended by Members of Ministerial Advisory Board to TMDA, Manegement and drugs inspectors from both TMDA and LGAs. The TMDA lake Zone Office serving six regions comprised of Mwanza, Mara, Simiyu, Kagera, Geita and Shinyanga.

First slide [1024x605]

The Ministerial Advisory Board (MAB) for TMDA has visited Sirari Ports of Entry on 14th September, 2020 to witness the regulatory functions before conducting its regular meeting in its Lake Zone offices based in Mwanza.

First slide [1024x605]

The Ministerial Advisory Board (MAB) for TMDA has visited Sirari Ports of Entry on 14th September, 2020 to witness the regulatory functions before conducting its regular meeting in its Lake Zone offices based in Mwanza.

First slide [1024x605]

A member of TMDA Workers Council, Mr. Moses Magoma, stressing a point when contributing to an agenda during a meeting that was held from 3rd to 4th September, 2020 in Morogoro. The TMDA Workers Council meets biannually to discuss the implementation of the institutional Strategic objectives as well as workers well-being.

First slide [1024x605]

Members of the TMDA Workers Council are in a group photo during the 4th meeting that was held in Morogoro from 3rd -4th September, 2020 to discuss various issues regarding the implementing the Strategic Plan as well as staff’s well-being.

First slide [1024x605]

A cross section of TMDA Workers Council attentively listening to the on-going discussions in one of the agenda presented during their biannual meetings that was held in Morogoro from 3rd-4th September, 2020

Latest News

More News

Online Service Icon

Online Service

Registered Product Icon

Registered Products

TMDA Guidelines Icon

TMDA Guidelines

Customer Feedback Icon

Customer Feedback

Online Support

Toll free Services: 0800 110 084
Medicine Registration: medicines@tmda.go.tz
Clinical Trials: clinicaltrials@tmda.go.tz
Medical Devices and IVD: medicaldevices@tmda.go.tz
Import and Export, GMP: enforcement@tmda.go.tz

View More

Latest News

15^th Jan, 2021

Invitation for Comments on a Draft of The Tanzania Medicines and Medical Devices (Good Storage and Distribution Practices) Regulations, 2021

10^th Dec, 2020

Ufafanuzi Kuhusu Ulipaji wa Malipo kwa Ajili ya Tafiti za Majaribio ya Dawa Zinazofanywa na Wanafunzi wa Vyuo vya Elimu ya Juu

10^th Dec, 2020

Clarification on Fees and Charges for Academic Research

30^th Nov, 2020

Online System for Submission of Applications for Withdrawal of Marketing Authorizations of Medicinal Products and Change of Local Technical Representa

30^th Nov, 2020

Submission of Product Samples along with Applications for Registration And Re-Registration of Medicinal Products

28^th Nov, 2020

Inaugural speech made by the Chief Medical Officer - Prof Abel Makubi at the kick-off meeting slated to launch the EDCTP funded project - ASCEND